Evaluation of subclinical organ damage for risk assessment and treatment in the hypertensive patient: Role of microalbuminuria

Journal of the American Society of Nephrology

Volumn 17, Issue SUPPL. 2, 2006, Pages

  Pontremoli, Roberto ^a,b   Leoncini, Giovanna ^c   Viazzi, Francesca ^c   Ratto, Elena ^c   Vaccaro, Valentina ^c   Falqui, Valeria ^c   Parodi, Angelica ^c   Conti, Novella ^c   Tomolillo, Cinzia ^c   Deferrari, Giacomo ^c  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN;

ANTIHYPERTENSIVE THERAPY; CARDIOVASCULAR RISK; CONFERENCE PAPER; DISEASE MARKER; HUMAN; HYPERTENSION; MICROALBUMINURIA; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; VASCULAR DISEASE;

EID: 33645471239     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1681/ASN.2005121327     Document Type: Conference Paper

References (13)

1. King H, Aubert RE, Herman WH: Global burden of diabetes, 1995-2025: Prevalence, numerical estimates, and projections. Diabetes Care 21: 1414-1431, 1998
2. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J: Global burden of hypertension: Analysis of worldwide data. Lancet 365: 217-223, 2005
3. European Society of Hypertension-European Society of Cardiology Guidelines Committee: 2003 European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens 21: 1011-1053, 2003
4. Ogden LG, He J, Lydick E, Whelton PK: Long-term absolute benefit of lowering blood pressure in hypertensive patients according to the JNC VI risk stratification. Hypertension 35: 539-543, 2000
5. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ: National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 289: 2560-2572, 2003
6. Parving HH, Mogensen CE, Jensen HA, Evrin PE: Increased urinary albumin-excretion rate in benign essential hypertension. Lancet 1: 1190-1192, 1974
7. Pontremoli R, Ravera M, Bezante GP, Viazzi F, Nicolella C, Berruti V, Leoncini G, Del Sette M, Brunelli C, Tomolillo C, Deferrari G: Left ventricular geometry and function in patients with essential hypertension and microalbuminuria. J Hypertens 17: 993-1000, 1999
8. Wachtell K, Ibsen H, Olsen MH, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, Beevers G, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Kristianson K, Lederballe-Pedersen O, Nieminen MS, Okin PM, Omvik P, Oparil S, Wedel H, Snapinn SM, Aurup P: Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy. The LIFE study. Ann Intern Med 139: 901-906, 2003
9. Klausen KP, Scharling H, Jensen G, Jensen JS: New definition of microalbuminuria in hypertensive subjects: Association with incident coronary heart disease and death. Hypertension 46: 33-37, 2005
10. Ibsen H, Olsen MH, Wachtell K, Borch-Johnsen K, Lindholm LH, Mogensen CE, Dahlof B, Devereux RB, de Faire U, Fyhrquist F, Julius S, Kjeldsen SE, Lederballe-Pedersen O, Nieminen MS, Omvik P, Oparil S, Wan Y: Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients: Losartan intervention for endpoint reduction in hypertension study. Hypertension 45: 198-202, 2005
11. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Smith G, Nieminen MS, Dahlof B, Ibsen H, Devereux RB: Albuminuria predicts cardiovascular events independently of left ventricular mass in hypertension: A LIFE substudy. J Hum Hypertens 18: 453-459, 2004
12. Viazzi F, Parodi D, Leoncini G, Vettoretti S, Ratto E, Vaccaro V, Ravera M, Tomolillo C, Bezante GP, Del Sette M, Deferrari G, Pontremoli R: Optimizing global risk evaluation in primary hypertension: The role of microalbuminuria and cardiovascular ultrasonography. J Hypertens 22: 907-913, 2004
13. Leoncini G, Sacchi G, Viazzi F, Ravera M, Parodi D, Ratto E, Vettoretti S, Tomolillo C, Deferrari G, Pontremoli R: Microalbuminuria identifies overall cardiovascular risk in essential hypertension: An artificial neural network-based approach. J Hypertens 20: 1315-1321, 2002